Endosomal sorting pathways in the pathogenesis of Parkinson's disease
- PMID: 32247367
- PMCID: PMC7206894
- DOI: 10.1016/bs.pbr.2020.02.001
Endosomal sorting pathways in the pathogenesis of Parkinson's disease
Abstract
The identification of Parkinson's disease (PD)-associated genes has created a powerful platform to begin to understand and nominate pathophysiological disease mechanisms. Herein, we discuss the genetic and experimental evidence supporting endolysosomal dysfunction as a major pathway implicated in PD. Well-studied familial PD-linked gene products, including LRRK2, VPS35, and α-synuclein, demonstrate how disruption of different aspects of endolysosomal sorting pathways by disease-causing mutations may manifest into PD-like phenotypes in many disease models. Newly-identified PD-linked genes, including auxilin, synaptojanin-1 and Rab39b, as well as putative risk genes for idiopathic PD (endophilinA1, Rab29, GAK), further support endosomal sorting deficits as being central to PD. LRRK2 may represent a nexus by regulating many distinct features of endosomal sorting, potentially via phosphorylation of key endocytosis machinery (i.e., auxilin, synaptojanin-1, endoA1) and Rab GTPases (i.e., Rab29, Rab8A, Rab10) that function within these pathways. In turn, LRRK2 kinase activity is critically regulated by Rab29 at the Golgi complex and retromer-associated VPS35 at endosomes. Taken together, the known functions of PD-associated gene products, the impact of disease-linked mutations, and the emerging functional interactions between these proteins points to endosomal sorting pathways as a key point of convergence in the pathogenesis of PD.
Keywords: Auxilin; Endolysosomal sorting; Endophilin; GAK; LRRK2; Parkinson's disease; Rab GTPases; Synaptic vesicle endocytosis; Synaptojanin-1; VPS35; α-Synuclein.
© 2020 Elsevier B.V. All rights reserved.
Figures
![Figure 1:](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7206894/bin/nihms-1582257-f0001.gif)
Similar articles
-
LRRK2 and the Endolysosomal System in Parkinson's Disease.J Parkinsons Dis. 2020;10(4):1271-1291. doi: 10.3233/JPD-202138. J Parkinsons Dis. 2020. PMID: 33044192 Free PMC article. Review.
-
Role of the endolysosomal system in Parkinson's disease.J Neurochem. 2019 Sep;150(5):487-506. doi: 10.1111/jnc.14820. Epub 2019 Jul 31. J Neurochem. 2019. PMID: 31287913 Free PMC article. Review.
-
Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations.Cells. 2020 Jul 17;9(7):1719. doi: 10.3390/cells9071719. Cells. 2020. PMID: 32709066 Free PMC article.
-
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.Trends Neurosci. 2019 Feb;42(2):140-149. doi: 10.1016/j.tins.2018.11.001. Epub 2018 Nov 30. Trends Neurosci. 2019. PMID: 30509690 Free PMC article. Review.
-
Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila.Hum Mol Genet. 2017 Aug 1;26(15):2933-2948. doi: 10.1093/hmg/ddx179. Hum Mol Genet. 2017. PMID: 28482024
Cited by
-
VPS35 and retromer dysfunction in Parkinson's disease.Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220384. doi: 10.1098/rstb.2022.0384. Epub 2024 Feb 19. Philos Trans R Soc Lond B Biol Sci. 2024. PMID: 38368930 Free PMC article. Review.
-
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.Mol Neurodegener. 2023 Aug 4;18(1):51. doi: 10.1186/s13024-023-00641-4. Mol Neurodegener. 2023. PMID: 37542299 Free PMC article.
-
The loss of function GBA1 c.231C > G mutation associated with Parkinson disease.J Neural Transm (Vienna). 2023 Jul;130(7):905-913. doi: 10.1007/s00702-023-02651-4. Epub 2023 Jun 6. J Neural Transm (Vienna). 2023. PMID: 37280314
-
The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson's disease.Front Cell Neurosci. 2023 Jan 10;16:1081426. doi: 10.3389/fncel.2022.1081426. eCollection 2022. Front Cell Neurosci. 2023. PMID: 36704248 Free PMC article. Review.
-
Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.Neurobiol Dis. 2022 Aug;170:105768. doi: 10.1016/j.nbd.2022.105768. Epub 2022 May 16. Neurobiol Dis. 2022. PMID: 35588987 Free PMC article. Review.
References
-
- ABELIOVICH A & GITLER AD 2016. Defects in trafficking bridge Parkinson's disease pathology and genetics. Nature, 539, 207–216. - PubMed
-
- ABELIOVICH A, SCHMITZ Y, FARINAS I, CHOI-LUNDBERG D, HO WH, CASTILLO PE, SHINSKY N, VERDUGO JM, ARMANINI M, RYAN A, HYNES M, PHILLIPS H, SULZER D & ROSENTHAL A 2000. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron, 25, 239–52. - PubMed
-
- ANDERSEN MA, WEGENER KM, LARSEN S, BADOLO L, SMITH GP, JEGGO R, JENSEN PH, SOTTY F, CHRISTENSEN KV & THOUGAARD A 2018. PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats. Toxicology, 395, 15–22. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous